The Brown University Center for Alcohol and Addiction Studies (CAAS) is an internationally renowned research center in alcohol research. The mission is twofold: to conduct collaborative research that will lead to more effective treatment for alcohol and drug abuse, and to create a nationwide program in substance abuse, education and training for psychologists, physicians, medical students, and health care professionals.
Through its affiliation with the Medical School and the School of Public Health, CAAS occupies a unique position within Brown University. The Center was established by Brown University in 1982 as part of the Division of Biology and Medicine, under the directorship of David Lewis, M.D. The Center is one of 20 centers at Brown established by the President of the University to encourage interdisciplinary scholarly work that cuts across traditional department lines. The Center’s research endeavors are continually reinforced by both the National Institutes of Health as well as by peer review journals at a pace that defies both the “leveling off” of the NIH budget and any cap on academic productivity.
Peter M. Monti, Ph.D., Center Director
Suzanne Colby, Ph.D., Associate Director
Jeffrey Griffin, Associate Director, Finance and Administration
Christopher Kahler, Ph.D., Associate Director, Chair of Behavioral and Social Sciences
Damaris Rohsenow, Ph.D., Associate Director
Robert Swift, M.D., Ph.D., Associate Director
The Brown University Center for Alcohol and Addiction Studies is located at 121 South Main St., Providence, RI.
CAAS Year In Review 2015
The Annual Center for Alcohol and Addiction Studies (CAAS) Year in Review and Postdoctoral Graduation was held on Thursday, June 11. Click here for details.
Jennifer Merrill presented a talk titled "Alcohol Consequences in Their Own Words: A Qualitative Examination among Young Adult Drinkers" at the 41st Annual Alcohol Epidemiology Symposium of the Kettil Bruun Society in Munich, Germany on June 1, 2015.
Sara Becker was invited to be a guest blogger for the American Psychological Association's Division of Clinical Psychology to discuss how direct-to-consumer marketing can potentially be applied to increase the use of effective treatments. Her piece can be viewed at the following link: https://www.div12.org/increasing-the-use-of-effective-behavioral-treatments-through-direct-to-consumer-marketing/
Caroline Kuo will present "Developing a family-based intervention for adolescent HIV prevention in South Africa" at the South African AIDS Conference in Durban, South Africa in June 2015.
Caroline Kuo will be serving on the scientific committee of the AIDS Impact Conference and presenting an oral paper, Developing a family intervention to build resilience for HIV prevention and mental health.
Molly Magill moderated the symposium titled 'What Can Process Research Do For You? A Tale of Three Types of Clinical Trial Outcomes' and presented 'Probing Non-Significant Matching Effects in a Large-Scale Clinical Trial' at the International Conference on the Treatment of Addictive Behaviors annual conference held in Odense, Denmark in June 2015. Other presenters at this symposium included Nadine Mastroleo and Lynn Hernandez. The discussant for this Symposium was Tim Apodaca.
Posted June 2015
Jennifer Tidey presented a talk entitled "Smoking and Psychiatric Illness: Why is there a connection? What can we do about it?" at Crossroads RI on 5/4/15.
Posted May 2015
Caroline C. Kuo, MPhil, DPhil is a behavioral and social scientist whose global public health research has focused on addressing HIV risk, psychological distress, and alcohol and substance use among HIV infected and affected families; men who have sex with men; incarcerated populations; and sex workers. She has conducted community-based epidemiological studies, mixed methods studies, and intervention development and testing in South Africa, Kenya, Mexico, and the USA. Her current research focuses on developing resilience-based interventions to address health disparities in families living in generalized endemic settings; the development of biobehavioral HIV prevention approaches; and testing of novel new interventions to reach and engage young people in HIV testing, treatment, and care.